New Business Opportunities and Investment Research in North America Genome Editing Market | Market Data Forecast
The North America
Genome Editing Market was worth USD 1.13 billion in 2016 and estimated to be
growing at a CAGR of 13.98%, to reach USD 2.18 billion by 2021. Genome editing
or gene editing is the insertion, deletion or replacement of DNA at a specific
site in the genome of an organism or a cell. It is usually carried out in a
laboratory using engineered nucleases which are alternatively called as
molecular scissors. There are a number of recognized gene editing methods which
have been used effectively in applying in a wide range of tissues and organisms
including human cancer cells and IPSCs.
Browse
market data tables and in-depth TOC of the North America Genome Editing Market
to 2021 @ https://www.marketdataforecast.com/market-reports/north-america-genome-editing-market-2792/
Genome Editing can be
categorized based on whether they result in the loss of function or gain of
function. In the former, functional forms of a genome are removed and the
effect is studied and in the latter new active forms of the genome are
introduced and the effect is studied. Some common examples of genome editing
are target validation, drug repurposing, studying modulators of gene
transcription and identifying lethal synthetic interactions.
The key drivers of
the Genome Editing Market in North America include the development of gene
therapy in the US and increasing use of GM crops. Other factors driving the
market include the high incidence of Alzheimer’s disease, dementia, cancer and
infectious diseases. The market is also driven by the growing availability of
research grants and funding and the numerous workshops and conferences held on
genome editing standards. Inspite of the numerous drivers, the market is hampered
by concerns such as ethicality of genome editing as brought up by human and
animal rights activists. Additionally, the market is restrained by the concern
of toxicity due to nucleases affecting non-target DNA sequences.
Free
sample of the report is available @ https://www.marketdataforecast.com/market-reports/north-america-genome-editing-market-2792/request-sample
The
North America Genome Editing market is broadly classified into Cell Line,
Animal Genetic and Plant Genetic Engineering in the basis of application, by
technology into CRISPR, TALEN, ZFN, Antisense and Other Technologies and on the
basis of end user into Biotechnological & Pharmaceutical Companies,
Academic and Government Research Institutes and Contract Research
Organizations. Based on geography, the North America market is analysed under
USA and Canada. North America is the largest market globally albeit with the second
lowest growth rate. The less than average growth rate is deemed acceptable due
to the highly developed nature of the market. This is also made up by the fact
that 40% of the total market revenue generated from genome editing comes from
the North American region.
The
Genome Editing market is highly competitive with a large number of players.
Some of the major ones are Thermo Fisher Scientific, Merck KGAA, Horizon
Discovery Group Plc, Genscript Biotech Corporation, Sangamo Biosciences,
Integrated DNA Technologies, Lonza Group Ltd, New England Biolabs, Origene
Technologies, and Transposagen Biopharmaceuticals.
Inquire before buying @
https://www.marketdataforecast.com/market-reports/north-america-genome-editing-market-2792/inquire
The
scope of the report provides:
·
The
evaluation of the current market for your product or services and the future
implications of the market
·
Addresses
the opportunities by better understanding the market through size estimates and
growth rate analysis to forecast the market for the future
·
Extensive
segmentation to understand the dynamics of market at a very granular level by
splitting down the market to the smallest segment
·
Addresses
the key market dynamics involving the drivers, restraints and challenges with
an aim of providing insights for gaining market share
·
The
factors responsible for the shaping of the industry as it is as a result of
competitive environment is analyzed through Porter’s Five Forces
·
The
effects of political, economic, social, technological, legal and environmental
factors on the industry is analyzed through PESTLE analysis to better
understand the aspects of strategic management required to comply with the
exogenous and endogenous factors
·
Strategic
evaluation of the key players to gain insights of their performance allowing
access to their product portfolio, financial performance and the strengths of
their business strategic developments
·
Comparative
study of the firms across the industry measuring their performances based on
market share and recent activities in order to achieve competitive intelligence
·
Equip
you with the information providing with the investment opportunities in the industry
Looking for more? If you are in need of a specific
research study, we have an expertise in undertaking a customized study and will
aid to meet your research requirement to the fullest.
Order
your copy of the report: https://www.marketdataforecast.com/cart/buy-now/north-america-genome-editing-market-2792/
About
Us:
Market Data Forecast
is a firm working in the area of market research and business intelligence.
With rich experience in research across various business domains, we cater to
the needs of both individual and corporate clients. Our analyst team comprises
expert professionals in market research, who with their collective knowledge and
skillset dedicatedly serve clients from various industries and regions.
Contact:
Abhishek Shukla
Sales
Manager (International Business Development)
Market
Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Comments
Post a Comment